Evaluation of the impact of a pertussis cocooning program on infant pertussis infection

Pediatric Infectious Disease Journal

Volumn 34, Issue 1, 2015, Pages 22-26

  Mary Healy, C ^a,b   Rench, Marcia A ^a   Wootton, Susan H ^c   Castagnini, Luis A ^a,b  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b TEXAS CHILDREN S HOSPITAL   (United States)

^c UNIVERSITY OF TEXAS   (United States)

Author keywords

Cocooning; Diphtheria and acellular pertussis; Infant infection; Pertussis; Tetanus

Indexed keywords

DIPHTHERIA PERTUSSIS TETANUS VACCINE;

ARTICLE; CHILD CARE; FEMALE; HOSPITALIZATION; HUMAN; IMMUNIZATION; INFANT; INFECTION PREVENTION; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; PERTUSSIS; PERTUSSIS COCOONING PROGRAM; PREGNANT WOMAN; PREVENTIVE MEDICINE; PRIORITY JOURNAL; PUERPERIUM; THIRD TRIMESTER PREGNANCY; IMMUNOLOGY; NEWBORN; PREGNANCY; TEXAS; WHOOPING COUGH;

DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINES; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; PREGNANCY; TEXAS; WHOOPING COUGH;

EID: 84924260554     PISSN: 08913668     EISSN: 15320987     Source Type: Journal    
DOI: 10.1097/INF.0000000000000486     Document Type: Article

References (38)

1. Roush SW, Murphy TV; Vaccine-Preventable Disease Table Working Group. Historical comparisons of morbidity and mortality for vaccine-preventable diseases in the United States. JAMA. 2007;298:2155-2163.
2. van Panhuis WG, Grefenstette J, Jung SY, et al. Contagious diseases in the United States from 1888 to the present. N Engl J Med. 2013;369:2152-2158.
3. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap) in pregnant women-Advisory Committee on Immunization Practices (ACIP), 2012. Morb Mortal Wkly Rep. 2013;62:131-135.
4. Mooi FR, de Greeff SC. The case for maternal vaccination against pertussis. Lancet Infect Dis. 2007;7:614-624.
5. 2012 Final Pertussis Surveillance Report. Available at: www.cdc.gov/pertussis/downloads/pertussis-surveillance-report.pdf. Accessed March 10, 2014.
6. Haberling DL, Holman RC, Paddock CD, et al. Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J. 2009;28:194-198.
7. Vitek CR, Pascual FB, Baughman AL, et al. Increase in deaths from pertussis among young infants in the United States in the 1990s. Pediatr Infect Dis J. 2003;22:628-634.
8. Winter K, Harriman K, Zipprich J, et al. California pertussis epidemic, 2010. J Pediatr. 2012;161:1091-1096.
9. Kretsinger K, Broder KR, Cortese MM, et al. Preventing tetanus, diphtheria, and pertussis among adults: use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine recommendations of the Advisory Committee on Immunization Practices (ACIP) and recommendation of ACIP, supported by the Healthcare Infection Control Practices Advisory Committee (HICPAC), for use of Tdap among health-care personnel. Morb Mortal Wkly Rep. 2006;55:1-37.
10. Bisgard KM, Pascual FB, Ehresmann KR, et al. Infant pertussis: who was the source? Pediatr Infect Dis J. 2004;23:985-989.
11. de Greeff SC, de Melker HE, Westerhof A, et al. Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology. 2012;23:852-860.
12. Wendelboe AM, Njamkepo E, Bourillon A, et al. Infant Pertussis Study Group. Transmission of Bordetella pertussis to young infants. Pediatr Infect Dis J. 2007;26:293-299.
13. Van Rie A, Hethcote HW. Adolescent and adult pertussis vaccination: computer simulations of five new strategies. Vaccine. 2004;22:3154-3165.
14. Dylag AM, Shah SI. Administration of tetanus, diphtheria, and acellular pertussis vaccine to parents of high-risk infants in the neonatal intensive care unit. Pediatrics. 2008;122:e550-e555.
15. Healy CM, Rench MA, Baker CJ. Implementation of cocooning against pertussis in a high-risk population. Clin Infect Dis. 2011;52:157-162.
16. Walter EB, Allred N, Rowe-West B, et al. Cocooning infants: Tdap immunization for new parents in the pediatric office. Acad Pediatr. 2009;9:344-347.
17. Healy CM, Rench MA, Castagnini LA, et al. Pertussis immunization in a high-risk postpartum population. Vaccine. 2009;27:5599-5602.
18. Castagnini LA, Healy CM, Rench MA, et al. Impact of maternal postpartum tetanus and diphtheria toxoids and acellular pertussis immunization on infant pertussis infection. Clin Infect Dis. 2012;54:78-84.
19. Centers for Disease Control and Prevention. Updated recommendations for use of tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Tdap) in pregnant women and persons who have or anticipate having close contact with an infant aged <12 months-Advisory Committee on Immunization Practices (ACIP), 2011. Morbid Mortal Wkly Rep. 2011;60:1424-1426.
20. Mills B, Fensterheim L, Taitel M, et al. Pharmacist-led Tdap vaccination of close contacts of neonates in a women's hospital. Vaccine. 2014;32:521-525.
21. Halperin BA, Morris A, Mackinnon-Cameron D, et al. Kinetics of the antibody response to tetanus-diphtheria-acellular pertussis vaccine in women of childbearing age and postpartum women. Clin Infect Dis. 2011;53:885-892.
22. Weston WM, Friedland LR, Wu X, et al. Vaccination of adults 65 years of age and older with tetanus toxoid, reduced diphtheria toxoid and acellular pertussis vaccine (Boostrix (®)): results of two randomized trials. Vaccine. 2012;30:1721-1728.
23. Klein NP, Bartlett J, Fireman B, et al. Comparative effectiveness of acellular versus whole-cell pertussis vaccines in teenagers. Pediatrics. 2013;131:e1716-e1722.
24. Misegades LK, Winter K, Harriman K, et al. Association of childhood pertussis with receipt of 5 doses of pertussis vaccine by time since last vaccine dose, California, 2010. JAMA. 2012;308:2126-2132.
25. Warfel JM, Zimmerman LI, Merkel TJ. Acellular pertussis vaccines protect against disease but fail to prevent infection and transmission in a nonhuman primate model. Proc Natl Acad Sci U S A. 2014;111:787-792.
26. Centers for Disease Control and Prevention. Noninfluenza vaccination coverage among adults-United States, 2011. Morbid Mortal Wkly Rep. 2013;62:66-72.
27. Healy CM, Munoz FM, Rench MA, et al. Prevalence of pertussis antibodies in maternal delivery, cord, and infant serum. J Infect Dis. 2004;190:335-340.
28. Healy CM, Rench MA, Edwards KM, et al. Pertussis serostatus among neonates born to Hispanic women. Clin Infect Dis. 2006;42:1439-1442.
29. Shakib JH, Ralston S, Raissy HH, et al. Pertussis antibodies in postpartum women and their newborns. J Perinatol. 2010;30:93-97.
30. Lichty JA, Slavin B, Bradford WL. An attempt to increase resistance to pertussis in newborn infants by immunizing their mothers during pregnancy. J Clin Invest. 1938;17:613-621.
31. Englund JA, Anderson EL, Reed GF, et al. The effect of maternal antibody on the serologic response and the incidence of adverse reactions after primary immunization with acellular and whole-cell pertussis vaccines combined with diphtheria and tetanus toxoids. Pediatrics. 1995;96:580-584.
32. Munoz FM, Bond NH, Maccato M, et al. Tetanus diphtheria and acellular pertussis (Tdap) immunization of pregnant women and infant responses to diphtheria, tetanus and acellular pertussis (DTaP) vaccine: a randomized clinical trial. JAMA. 2014;311:1760-1769.
33. Centers for Disease Control and Prevention. Influenza vaccination coverage among pregnant women-United States, 2012-13 influenza season. Morbid Mortality Wkly Rep. 2013;62:787-792.
34. Beel ER, Rench MA, Montesinos DP, et al. Knowledge and attitudes of postpartum women toward immunization during pregnancy and the peripartum period. Hum Vaccin Immunother. 2013;9:1926-1931.
35. Healy CM, Baker CJ. Infant pertussis: what to do next? Clin Infect Dis. 2012;54:328-330.
36. Chiappini E, Stival A, Galli L, et al. Pertussis re-emergence in the postvaccination era. BMC Infect Dis. 2013;13:151.
37. 2020 Topics and Objectives: Immunization and Infectious Diseases. Available at: http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId=23#. Accessed January 14, 2014.
38. Flu Vaccination Coverage, United States, 2012-13 Influenza Season. Available at: www.cdc.gov/flu/fluvaxview/coverage-1213estimates.htm. Accessed January 14, 2014.